Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Apellis Pharmaceuticals (APLS) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 15 quarters since 2018. Compare with APLS stock chart to see long term trends.

APLS Stock Compared to Quarterly

APLS Income Statement

Revenue, Net:5650000
Revenue Per Share:0.06
Research & Development Expense:87733000
Total Operating Expenses:133645000
Operating Income:-127995000
Net Income:-195571000
Earnings Per Share, Basic:-2.28
Shares Outstanding, Basic Avg:87295371

APLS Cash Flow

Operating Activities Net Income:
Net Cash from Operations:-168625000
Net Cash from Financing Activities:2120000
Property, Plant & Equipment Purchases:352000
Net Cash from Investing Activities:179649000
Net Change in Cash & Equivalents:12972000

APLS Balance Sheet

Cash and Cash Equivalents:285308000
Short-Term Investments:146566000
Accounts Receivable, Net:3522000
Inventories:1677000
Total Current Assets:475427000
Property, Plant & Equipment, Net:6509000
Total Assets:525689000
Accounts Payable:4984000
Total Short-Term Liabilities:94237000
Total Liabilities:583014000

Insider Trading

Change
Value
Transaction
SEC Form 4
Morningside Venture Investments Ltd   10% Owner
250,000 sh at $40
$10,000,000
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Wellington Management Group Llp
11,171,572 sh
457,747 sh
4%
$368,216
-$308,897
Vanguard Group Inc
6,752,285 sh
407,829 sh
6%
$222,555
-$178,414
Blackrock Inc.
5,466,191 sh
-204,541 sh
-4%
$180,168
-$178,221
Avoro Capital Advisors LLC
5,000,000 sh
4,760,000 sh
1983%
$164,800
$161,440
Price T Rowe Associates Inc /Md/
4,807,077 sh
-363,417 sh
-7%
$158,441
-$168,334
State Street Corp
2,826,195 sh
879,227 sh
45%
$93,151
-$29,897
Jennison Associates LLC
2,078,845 sh
-370,679 sh
-15%
$68,519
-$86,291
Citadel Advisors LLC
1,858,432 sh
1,769,532 sh
1990%
$61,254
$55,636
Victory Capital Management Inc
1,770,807 sh
114,519 sh
7%
$58,366
-$46,311
FMR LLC
1,614,859 sh
143,694 sh
10%
$53,226
-$39,752
Octagon Capital Advisors LP
1,595,911 sh
339,646 sh
27%
$52,601
-$26,795
JPMorgan Chase & Co
1,533,142 sh
1,118,049 sh
269%
$50,532
$24,299
Avoro Capital Advisors LLC
Call options for 1,515,000 sh
1,515,000 sh
NEW
$1,260
$1,260
Logos Global Management Lp
1,450,000 sh
1,100,000 sh
314%
$47,792
$25,672
Geode Capital Management, LLC
1,188,392 sh
70,257 sh
6%
$39,169
-$31,497
Macquarie Group Ltd
1,120,090 sh
574,416 sh
105%
$36,918
$2,431
Goldman Sachs Group Inc
1,023,170 sh
329,130 sh
47%
$33,724
-$10,140
Cormorant Asset Management, Lp
925,000 sh
75,000 sh
9%
$30,488
-$23,232
Jefferies Group LLC
888,104 sh
828,504 sh
1390%
$29,272
$25,505
Jane Street Group, LLC
Put options for 834,300 sh
834,300 sh
NEW
$27,499
$27,499

Data imported from Apellis Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.